Clinical trial
Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines
NCT00463437 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 25, 2007
- Completion date
- June 14, 2008
- Enrollment
- 1,437 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.
acellular pertussis, diphtheria, hepatitis b, poliomyelitis, streptococcus pneumoniae vaccines, tetanus